Article
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study.
Expert opinion on drug safety - 1 Jul 2021
Pugliese Nicola, Giorgini Alessia, Maggi Daniela, Capogreco Antonio, Dibenedetto Clara, Lubrano Lobianco Federica, Dal Buono Arianna, Monico Sara, Meli Rossella, Battezzati Pier Maria, Lleo Ana, De Santis Adriano, Zuin Massimo, Aghemo Alessio
Abstract excerpt
Background: Treatment of chronic Hepatitis C with directly acting antivirals (DAAs) can bring to sustained virologic response (SVR) in approximately 95% of patients. Efficacy and safety of DAAs in aging patients has not been widely analyzed. We aimed to determine safety and efficacy of DAA-based regimens in a cohort of elderly patients in a real-life setting.Research Design and Methods: We retrospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
